Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial

Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The Malmö, Sweden entry replaces Malmo, Sweden, 211 46 to reflect the proper Swedish spelling in the study locations.
    Difference
    0.0%
    Check dated 2026-05-02T22:56:42.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The page’s displayed software/version revision indicator was updated from v3.5.2 to v3.5.3.
    Difference
    0.0%
    Check dated 2026-04-25T16:49:31.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T13:02:14.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision: v3.5.0 added; v3.4.3 removed.
    Difference
    0.0%
    Check dated 2026-03-20T19:48:59.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:24:41.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    Revision: v3.4.2 is now displayed in place of Revision: v3.4.1; this appears to be a minor version update with no impact on the study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T11:57:18.000Z thumbnail image

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.